Literature DB >> 6610221

Intensive health screening of young black diabetics.

G V Gill, K R Huddle, L P Krige.   

Abstract

Black-insulin-dependent diabetics under the age of 30 years attending a busy South African diabetic clinic were intensively screened for a 4-month period. In the 66 patients studied, the following previously undiagnosed conditions were discovered: cataract (1), peripheral neuropathy (16), retinopathy (8), tuberculosis (4) and anaemia (3). In addition, 29 (43,9%) were on insulin regimens that were not ideal. Attempts were made to improve glycaemic control, especially in those patients with complications, and defective insulin regimens were corrected. The screening programme was carried out with normal manpower and investigative facilities, and the extra time involved was not excessive. This programme could be used (in either an expanded or a limited form) in any diabetic clinic, and would probably considerably improve the health of young insulin-dependent diabetic patients.

Entities:  

Mesh:

Year:  1984        PMID: 6610221

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Diabetic eye disease in Central Africa.

Authors:  M Rolfe
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

2.  'Cough-triggered' tuberculosis screening among adults with diabetes in Tanzania.

Authors:  G Mtwangambate; S E Kalluvya; B R Kidenya; R Kabangila; J A Downs; L R Smart; D W Fitzgerald; R N Peck
Journal:  Diabet Med       Date:  2013-11-18       Impact factor: 4.359

Review 3.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

Review 4.  Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies.

Authors:  Andrew Bastawrous; Philip I Burgess; Abdull M Mahdi; Fatima Kyari; Matthew J Burton; Hannah Kuper
Journal:  Trop Med Int Health       Date:  2014-01-31       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.